Glycyrrhizin ameliorates metabolic syndrome-induced liver damage in experimental rat model

Molecular and Cellular Biochemistry

Volumn 409, Issue 1-2, 2015, Pages 177-189

  Sil, Rajarshi ^a   Ray, Doel ^a,b   Chakraborti, Abhay Sankar ^a  

^a UNIVERSITY OF CALCUTTA   (India)

^b JAWAHARLAL NEHRU UNIVERSITY   (India)

Author keywords

Apoptosis; Glycyrrhizin; Inflammation; Liver damage; Metabolic syndrome; Oxidative stress

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CYCLOOXYGENASE 2; FRUCTOSE; GLYCYRRHIZIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; LIPOCORTIN 5; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C ALPHA; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR; ANTIINFLAMMATORY AGENT; GLUCOSE BLOOD LEVEL; GLUTATHIONE; INSULIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; EXPERIMENTAL RAT; FLUORESCENCE ACTIVATED CELL SORTING; GLYCYRRHIZA GLABRA; HEPATITIS; LIPID PEROXIDATION; LIVER CELL DAMAGE; LIVER INJURY; MALE; METABOLIC SYNDROME X; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; ANIMAL; APOPTOSIS; BLOOD; DRUG EFFECTS; GLUCOSE BLOOD LEVEL; INFLAMMATION; INJURIES; LIVER; LIVER DISEASES; METABOLISM; MITOCHONDRION; PATHOLOGY; WISTAR RAT;

ALANINE TRANSAMINASE; ANIMALS; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; ASPARTATE AMINOTRANSFERASES; BLOOD GLUCOSE; DNA DAMAGE; FRUCTOSE; GLUTATHIONE; GLYCOSYLATION END PRODUCTS, ADVANCED; GLYCYRRHIZIC ACID; INFLAMMATION; INSULIN; LIVER; LIVER DISEASES; MALE; METABOLIC SYNDROME X; MITOCHONDRIA; NF-KAPPA B; OXIDATIVE STRESS; POLY(ADP-RIBOSE) POLYMERASES; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; TRIGLYCERIDES;

EID: 84942880971     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-015-2523-y     Document Type: Article

References (77)

1. Eckel RH, Grundy SM, Zimmet PZ (2005) The metabolic syndrome. The Lancet 365:1415–1428
2. Watanabe S, Yaginuma R, Ikejima K, Miyazaki A (2008) Liver diseases and metabolic syndrome. J Gastroenterol 43:509–518
3. Dekker MJ, Su Q, Baker C, Rutledge AC, Adeli K (2010) Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome. Am J Physiol Endocrinol Metab 299:685–694
4. Tran LT, Yuen VG, McNeil JH (2009) The fructose-fed rat: a review on the mechanisms of fructose-induced insulin resistance and hypertension. Mol Cell Biochem 332:145–159
5. Radziuk J, Pye S (2007) The liver, glucose homeostasis, and insulin action in type 2 diabetes mellitus. In: Hansen BC, Bray GA (eds) Contempory endocrinology: the metabolic syndrome: epidemiology, clinical treatment and underlying mechanisms. Humana Press, New York, pp 343–371
6. Seven A, Guzel S, Seymen O, Civelek S, Bolayirh M, Uncu M, Burcak G (2004) Effect of vitamin E supplementation on oxidative stress in streptozotocin induced diabetic rats: investigation of liver and plasma. Yonsei Med J 45:703–710
7. Kelley GL, Allan G, Azhar S (2004) High dietary fructose induces a hepatic stress response resulting in cholesterol and lipid dysregulation. Endocrinology 145:548–555
8. Xiao J, Fai So K, Liong EC, Tipoe GL (2013) Recent advances in the herbal treatment of non-alcoholic fatty liver disease. J Tradit Complement Med 3:88–94
9. Howes MJ, Simmonds MS (2014) The role of phytochemicals as micronutrients in health and disease. Curr Opin Clin Nutr Metab Care 17:558–566
10. Kato H, Kanaoka M, Yano S, Kobayashi M (1995) 3-Monoglucuronyl-glycyrrhetinic acid is a major metabolite that causes licorice-induced pseudoaldosteronism. J Clin Endocrinol Metab 80:1929–1933
11. Serra A, Uehlinger DE, Ferrari P, Disk B, Frey BM, Frey FJ, Voqt B (2002) Glycyrrhetinic acid decreases plasma potassium concentrations in patients with anuria. J Am Soc Nephrol 13:191–196
12. Glavac NK, Kreft S (2012) Excretion profile of glycyrrhizin metabolite in human urine. Food Chem 131:305–308
13. Yu J, Jiang YS, Jiang Y, Peng YF, Sun Z, Dai XN, Cao QT, Sun YM, Han JC, Gao YJ (2014) Targeted metabolomic study indicating glycyrrhizin’s protection against acetaminophen-induced liver damage through reversing fatty acid metabolism. Phytother Res 28:933–936
14. Fernando HA, Chandramouli C, Rosli D, Lam YL, Yong ST, Yaw HP, Ton SH, Kadir KA, Sainsbury A (2014) Glycyrrhizic acid can attenuate metabolic deviations caused by a High-sucrose diet without causing water retention in male Sprague-Dawley rats. Nutrients 6:4856–4871
15. Wang W, Zhao F, Fang Y, Li X, Shen L, Cao T, Zhu H (2013) Glycyrrhizin protects against porcine endotoxemia through modulation of systemic inflammatory response. Crit Care 17:R44. doi:10.1186/cc12558
16. Chia YY, Liong SY, Ton SH, Kadir KB (2012) Amelioration of glucose homeostasis by glycyrrhizic acid through gluconeogenesis rate-limiting enzymes. Eur J Pharmacol 677:197–202
17. Xu-ying W, Ming L, Xiao-dong L, Ping H (2009) Hepatoprotective and anti-hepatocarcinogenic effects of glycyrrhizin and matrine. Chem Biol Int 181:15–19
18. Nagai T, Egashira T, Kudo Y, Yamanaka Y, Shimada T (1992) Attenuation of dysfunction in the ischemia-reperfused liver by glycyrrhizin. Jpn J Pharmacol 58:209–218
19. Mizoguchi Y, Katoh H, Tsutsui H, Yamamoto S, Morisawa S (1985) Protection of liver cells from experimentally induced liver cell injury by glycyrrhizin. Gastroenterol Jpn 20:99–103
20. Sen S, Roy M, Chakraborti AS (2011) Ameliorative effect of glycyrrhizin on streptozotocin-induced diabetes in rats. J Pharm Pharmacol 63:287–296
21. Kalaiarasi P, Pugalendi KV (2009) Antihyperglycemic effect of 18β-glycyrrhetinic acid, aglycone of glycyrrhizin, on streptozotocin-diabetic rats. Eur J Pharmacol 606:269–273
22. Eu CH, Lim WY, Ton SH, Kadir KA (2010) Glycyrrhizic acid improved lipoprotein lipase expression, insulin sensitivity, serum lipid and lipid deposition in high-fat diet-induced obese rats. Lipids Health Dis. doi:10.1186/1476-511X-9-81
23. Chandramouli C, Ting YS, Lyn LY, Ha TS, Kadir KA (2011) Glycyrrhizic acid improves lipid and glucose metabolism in high-sucrose-fed rats. J Endocrinol Metab 1:125–141
24. Sil R, Ray D, Chakraborti AS (2013) Glycyrrhizin ameliorates insulin resistance, hyperglycemia, dyslipidemia and oxidative stress in fructose-induced metabolic syndrome-X in rat model. Indian J Exp Biol 51:129–138
25. Reitman S, Frankel S (1957) A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am J Clin Pathol 28:56–63
26. Thambidorai D, Bachawat BK (1977) Purification and properties of brain alkaline phosphatase. J Neurochem 29:503–512
27. Amador E, Wacker W (1962) Serum glutamic oxalacetic transaminase activity. A new modification and an analytical assessment of current assay techniques. Clin Chem 8:343–350
28. Ellman GL (1959) Tissue sulphydryl groups. Arch Biochem Biophys 82:70–77
29. Lowry OH, Rosebrough NJ, Farr AL, Randal RJ (1951) Protein measurement with the Folin phenol reagents. J Biol Chem 193:265–275
30. Nandhini AT, Balakrishnan SD, Anuradha CV (2002) Taurine improves lipid profile in rats fed a high fructose-diet. Nutr Res 22:343–354
31. Buege JA, Aust SD (1978) Microsomal lipid peroxidation. Methods Enzymol 52:302–310
32. Levine RC, Garland D, Oliver CN, Amiei A, Climent I, Lanz A, Ahn B, Shalleil SO, Stadtman ER (1990) Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 186:464–478
33. Nakayama H, Mitsuhashi T, Kuwajima S, Aoki S, Kuroda Y, Itoh T, Nakagawa S (1993) Immunochemical detection of advanced glycation end products in lens crystallins from streptozotocin-induced diabetic rat. Diabetes 42:345–350
34. Carlberg I, Mannervik B (1985) Glutathione reductase. Methods Enzymol 113:484–490
35. Rotruck JJ, Pope AL, Gantter HE, Swanson AB (1973) Selenium: biochemical role as a component of glutathione peroxidase. Science 179:588–590
36. Habig WH, Pabst MJ, Jakoby WB (1974) Glutathione-S-transferase. The first enzymatic step in mercapturic acid formation. J Biol Chem 249:7130–7139
37. Kim HY, Okubo T, Juneja LR, Yokozawa T (2010) The protective role of amla (Emblica officinalis Gaertn.) against fructose-induced metabolic syndrome in a rat model. Br J Nutr 103:502–512
38. Berman SB, Hastings TG (1999) Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson’s disease. J Neurochem 73:1127–1137
39. Cohen G, Farooqui R, Kesler N (1997) Parkinson disease: a new link between monoamine oxidase and mitochondrial electron flow. Proc Natl Acad Sci 94:4890–4894
40. Luo J, Shi R (2005) Acrolein induces oxidative stress in brain mitochondria. Neurochem Int 46:243–252
41. Sellins KS, Cohen JJ (1987) Gene induction by gamma-irradiation leads to DNA fragmentation in lymphocytes. J Immunol 139:3199–3206
42. Sarkar MK, Sil PC (2010) Prevention of tertiary butyl hydroperoxide induced oxidative impairment and cell death by a novel antioxidant protein molecule isolated from the herb, Phyllanthus niruri. Toxicol Vitro 24:1711–1719
43. Cossarizza A, Baccarani-Contri M, Kalashnikova G, Franceschi C (1993) A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5′,6,6′-tetrachloro-1,1′,3,3′ tetraethylbenzimidazolylcarbocyanine iodide (JC-1). Biochem. Biophys Res Commun 197:40–45
44. Preece A (1972) A manual for histologic technicians. Little, Brown and Co, Boston
45. Isbrucker RA, Burdock GA (2006) Risk and safety assessment on the consumption of Licorice root (Glycyrrhiza sp.), its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of glycyrrhizin. Regul Toxicol Pharmacol 46:167–192
46. Yamamura Y, Santa T, Kotaki H, Uchino K, Sawada Y, Iga T (1995) Administration-route dependency of absorption of glycyrrhizin in rats: intraperitoneal administration dramatically enhanced bioavailability. Biol Pharm Bull 18:337–341
47. Zhai D, Zhao Y, Chen X, Guo J, He H, Yu Q, Yang J, Davey AK, Wang J (2007) Protective effect of glycyrrhizin, glycyrrhetic acid and matrine on acute cholestasis induced by alpha-naphthyl isothiocyanate in rats. Planta Med 73:128–133
48. Yogalakshmi B, Bhuvaneswari S, Sreeja S, Anuradha CV (2014) Grape seed proanthocyanidins and metformin act by different mechanisms to promote insulin signaling in rats fed high calorie diet. J Cell Commun Signal 8:13–22
49. Sivakumar AS, Anuradha CV (2011) Effect of galangin supplimentation on oxidative damage and inflammatory changes in fructose-fed rat liver. Chem Biol Interact 193:141–148
50. Rajasekar P, Viswanathan P, Anuradha CV (2008) Beneficial impact of L-carnitine in liver: a study in a rat model of syndrome X. Amino Acids 35:475–483
51. Kowaltowski AJ, De Souza-Pinto NC, Castilho RF, Vercesi AE (2009) Mitochondria and reactive oxygen species. Free Radic Biol Med 47:333–343
52. Gopalakrishna R, Jaken S (2000) Protein kinase C signaling and oxidative stress. Free Radic Biol Med 28:1349–1361
53. Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Aoki T, Etoh T, Hashimoto T, Naruse M, Sano H, Utsumi H, Nawata H (2000) High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49:1939–1945
54. Baynes JW (1991) Role of oxidative stress in development of complications in diabetes. Diabetes 40:405–412
55. Ruderman NB, Williamson JR, Brownlee M (1992) Glucose and diabetic vascular disease. FASEB J 6:2905–2914
56. Pompella A, Visvikis A, Paolicchi A, De Tata V, Casini AF (2003) The changing faces of glutathione, a cellular protagonist. Biochem Pharmacol 66:1499–1503
57. Baldwin AS (2001) The transcription factor NF-kB and human disease. J Clin Invest 107:3–6
58. Tomlinson DR (1999) Mitogen-activated protein kinases as glucose transducers for diabetic complications. Diabetologia 42:1271–1281
59. Verzola D, Bertolotto MB, Villaggio B, Ottonello L, Dallegri F, Frumento G, Berruti V, Gandolfo MT, Garibotto G, Deferran G (2002) Taurine prevents apoptosis induced by high glucose in human tubule renal cells. J Invest Med 50:443–451
60. Smiley ST, Reers M, Mottola-Hartshorn C, Lin M, Chen A, Smith TW, Steele GD, Chen LB (1991) Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate forming lipophilic cation JC-1. Proc Natl Acad Sci USA 88:3671–3675
61. Packard BZ, Toptygin DD, Komoriya A, Brand L (1996) Profluorescent protease substrates: intramolecular dimmers described by the exciton model. Proc Natl Acad Sci USA 93:11640–11645
62. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C (1995) A novel assay for apoptosis-flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J Immunol Methods 184:39–51
63. Mukhopadhyay S, Farver CF, Vaszar LT, Dempsey OJ, Popper HH, Mani H, Capelozzi VL, Fukuoka J, Kerr KM, Zeren EH, Iyer VK, Tanaka T, Narde I, Nomikos A, Gumurdulu D, Arava S, Zander DS, Tazelaar HD (2012) Causes of pulmonary granulomas: a retrospective study of 500 cases from seven countries. J Clin Pathol 65:51–57
64. Quagliaro L, Piconi L, Assaloni R, Martinelli L, Motz E, Ceriello A (2003) Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. Diabetes 52:2795–2804
65. Ramasamy R, Vannucci SJ, Yan SSD, Herold K, Yan SF, Schmidt M (2005) Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology 15:16R–28R
66. Delbosc S, Paizanis E, Magous R, Araiz C, Dimo T, Cristol JP, Cros G, Azay J (2005) Involvement of oxidative stress and NADPH oxidase activation in the development of cardiovascular complications in a model of insulin resistance, the fructose-fed rat. Atherosclerosis 179:43–49
67. Roberts CK, Sindhu KK (2009) Oxidative stress and metabolic syndrome. Life Sci 84:705–712
68. Li Q, Verma IM (2002) NF-kB regulation in the immune system. Nat Rev Immunol 2:725–734
69. Vermeulen L, De Wilde G, Van Damme P, Vanden Berghe W, Haegernan G (2003) Transcriptional activation of the NF-kappa B p65 subunit by mitogen- and stress activated protein kinase-1 (MSK1). EMBO J 22:1313l–1324l
70. Bertolini A, Ottani A, Sandrini M (2002) Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks. Curr Med Chem 9:1033–1043
71. Trinchieri G (1994) Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-Helper cells type 1 and cytotoxic lymphocytes. Blood 84:4006–4027
72. Gwak GY, Moon TG, Lee DH, Yoo BC (2012) Glycyrrhizin attenuates HMGB1-induced hepatocyte apoptosis by inhibiting the p38-dependent mitochondrial pathway. World J Gastroenterol 18:679–684
73. Mollica L, Marchis FD, Spitaleri A, Dallacosta C, Pennacchini D, Zamai M, Agresti A, Trisciuoglio L, Musco G, Bianchi ME (2007) Glycyrrhizin binds to high-mobility group box 1 protein and inhibits its cytokine activities. Chem Biol 14:431–441
74. Sitia G, Iannacone M, Müller S, Bianchi ME, Guidotti LG (2007) Treatment with HMGB1 inhibitors diminishes CTL-induced liver disease in HBV transgenic mice. J Leukoc Biol 81:100–107
75. Keeble JA, Gilmore AP (2007) Apoptosis commitment-translating survival signals into decisions on mitochondria. Cell Res 17:976–984
76. Elmore S (2007) Apoptosis: a review of programmed cell death. Toxicol Pathol 35:495–516
77. Ishak KG (1995) Granulomas in the liver. Adv Pathol Lab Med 8:247–361